Third Pole Therapeutics Announces First Patient Dosed in Feasibility Study With eNOfit™ Portable Inhaled Nitric Oxide Delivery System

-12-11 Associated Press https://apnews.com/press-release/globenewswire-mobile/lung-disease-6ee3fc4035f9e861fc7a70cba46abb36